SlideShare a Scribd company logo
1 of 20
1
Koyin Aladesuru
4/16/2015
HAP 752- AdvancedHealthInformationSystems
Semester Long Project
HIV (Human Immunodeficiency Disease)
Introduction:
There was once upon a time when the word HIV seemed like a taboo, and the mere mention of
the word could have one glance at you with a death sentence stare. HIV, also known as Human
Immunodeficiency Virus, spreads through body fluids that affect vital cells in the immune
system. Without treatment, HIV often leads to AIDS (Acquired Immunodeficiency Syndrome),
an advance stage of HIV that destroys several cells in the body and makes one prone to
opportunistic infections and diseases. HIV can be transmitted through a list of possible risk
factors such as number of sexual partners, condom usage, injection drug users, sexual
orientation, history of STD’s, or even geographical location. According to recent statistics
provided by the Center for Disease Control and Prevention (CDC), there are about 50,000 new
HIV infections per year and approximately 1.2 million people in the United States were living
with HIV at the end of 2011. Fortunately however, with the advancement of antiretroviral
therapy (ART) and proper medical care, HIV is no longer a death sentence. Antiretroviral
therapy, which was introduced in the mid-1990’s, has proven to be a life saver in the fight
against HIV. The goal of this project is to build a system that allows healthcare providers to
conduct a thorough risk assessment for HIV, recommend effective prevention methods, track
lab values for patients, show trend of values over time, detect abnormal results, and identify
adverse drug reactions.
Background:
HIV can be broken up into three stages:
1. Acute infection: This stage is typically within 2 to 4 weeks after infection of HIV, and the
word “acute” implies that this is when one is at the highest risk of spreading the disease.
This is also the period when one may display symptoms such as fever, fatigue, cough,
shortness of breath, sore throat, rash, and enlarge lymph nodes.
2. Clinical latency (inactivity or dormancy): This stage is often referred to as HIV
asymptomatic, where one may display little to no symptoms. Typically, people who are
adherent to antiretroviral therapy during this stage can maintain clinical latency for a
long period of time (usually several decades). Towards the latter end of this stage
however, the viral load (amount of virus in the blood) usually increases, while the CD4 T-
2
cells (white blood cells in the body) begins to drop. The immune systemgets weaker at
this point.
3. AIDS (Acquired Immunodeficiency Syndrome): As the immune system progressively
gets weaker, one becomes severely exposed to opportunistic infections and cancer.
When the CD4 count falls below 200 cells/mm^3, one may be diagnosed as AIDS.
Although, it is important to note that one can also be diagnosed as AIDS once one
develops one or more opportunistic infections, regardless of CD4 count. A normal range
for a CD4 count falls between 500 and 1,200 cells/mm^3. CDC points out that without
treatment, people diagnosed with AIDS survive an average of 3 years life expectancy.
HIV Testing
Know your HIV status- is the recurring mantra that has been floating around our society for
several decades. Risk assessment and routine testing for HIV is very important, particularly
amongst younger adults who may be at a higher risk of exposure. In the public health
community, it is not uncommon to hear that a sexually active person has never been tested for
HIV. ELISA, also known as Enzyme-Linked Immuno Assay, is a widely used laboratory test to
detect HIV antibodies in the blood. It can detect HIV as early as 3 weeks after exposure and if a
patient tests positive, they further undergo a confirmatory test, known as a Western Blot, to
confirm positivity. In order to screen out false-positive results, which happen in rare cases, it is
important to supplement an ELISA test with a Western Blot test. Subsequently, a clinician then
orders a Viral Load and CD4 test which we’ll discuss in the next few sections.
Viral Load
This is a term used to describe the amount of virus in the blood. In clinician language, viral Load
can be described as the number of copies of HIV RNA in a milliliter of blood. In simple terms,
the more HIV spreads in your blood, the higher your viral load. Viral load is a useful metric to
measure the health status of an HIV patient and the impact of antiretroviral therapy on their
health. It is recommended to look at a trend of viral load over time (we will discuss this later on
in the project). Compared to hypertension, diabetes, or some other chronic diseases, HIV does
not necessarily have a specific range/cutoff for a “normal” viral load. According to the Health
Resources and Services Administration (HRSA), viral count can be measured using the following
data criteria:
Suppressed (Undetectable level): < 200 copies/mL
Unsuppressed (Detectable level): > 200 copies /mL
CD4 Count:
CD4 T-cells, also known as “CD4 Count”, are white blood cells that protect the immune system.
A CD4 test measures the amount of T-cells in the body. As the CD4 count decreases, the risk of
developing opportunistic infections increases. As I mentioned earlier, a CD4 count less than 200
cells/mm^3 is considered below normal range and it indicates that HIV is advancing to AIDS.
3
According to the Health Resources and Services Administration (HRSA), CD4 count can be
measured using the following data criteria:
Normal range: 500 – 1,200 cells/mm^3
Below normal range: < 200 cells/mm^3
PrEP:
Pre-exposure prophylaxis, also known as PrEP, is an effective prevention option for people who
are at high risk of getting HIV. CDC recommends PrEP for people who are HIV-negative but are
at substantial risk for the disease. PrEP is taking in the form of a pill called Truvada and is
recommended to be taking daily to prevent HIV. According to a PreP study conducted, the risk
of getting HIV infection was about 92% lower for patients who took Truvada consistently. Part
of this project will explore a scenario where a provider conducts a risk assessment for a patient
recently exposed to HIV, performs an HIV test (which comes back negative), and recommends
PreP as an effective risk reduction method.
ALERTS and Clinical Decision Support Systems (CDSS):
In order for health providers to make accurate and effective clinical decisions, a data system
should be able to trigger a series of alerts or warnings to guide them during treatment. Data
mining helps physicians, nurses, and other health professionals predict the likelihood of an
event occurring. This could range from risk stratification of a particular disease, to disease
management and adverse drug interactions. Keep in mind that it is important not to
overwhelm providers with alerts, particularly for less urgent clinical decisions.
A clinician will be able to achieve the following with this system:
1. Identify patients who are at risk of getting HIV
2. Prescribe PrEP as an effective prevention method
3. Monitor viral load count for HIV positive clients
4. Monitor CD4 count and prescribe PCP Prophylaxis if CD4 count drops below 200
5. Prescribe antiretroviral medications and check for any drug interactions/allergies
6. View a graphical trend of viral load performance
RequirementsSpecification:
Scenario 1
A patient comes in for a routine HIV test. A nurse/community health educator uses a risk
assessment screening tool to measure the patients risk for HIV. Out of 9 standardized
questions, if the patient answers “Yes” to 5 or more, an alert will be triggered as “high risk”.
4
The medical personnel will then perform an HIV (ELISA) test and if the test comes out negative,
a clinician will suggest/prescribe PreP as an effective risk reduction method.
Scenario name: Risk assessment and PrEP prescription
Decision made by the scenario: CDSS will help determine if patient is at substantial risk of
getting HIV and alert the provider to offer PrEP as a preventive option.
Actors: Medical Personnel, Patient
Description: The medical personnel can use the clinical decision support system to conduct a
risk assessment and prescribe PrEP to HIV-negative patients who are high risk of exposure to
HIV.
Use case name: CDSS utilization
Overview: HIV has a high correlation with sexual behaviors. The purpose of this use case is to
identify a patient who is at increased risk of exposure to the disease. If they answer yes to 5 or
more risk assessment questions, a provider will offer the option of PrEP in order to mitigate
their risk.
Primary actor: Medical staff (Phlebotomist, Nurse, Community Health educator)
Secondary actor: Clinicians
Start point: The medical staff performs a risk assessment of patient sexual behaviors. If patient
scores more than 5 out of 9 standardized questions, a “high risk alert” will pop up. Medical
personnel will the recommend an HIV test
End point: The provider reviews lab results and utilizes the clinical decision support systemto
offer PrEP to patient
Information Exchange: The information about potential risk factors is entered into a patient’s
sexual risk assessment screening tool. The provider will use the CDSS tool to identify if the
patient is high risk, perform HIV test, and recommend risk prevention treatment as needed i.e.
PrEP.
Scenario 2:
A patient walks in for a routine HIV test. The medical personnel administer an ELISA test and
the result comes back positive. Provider conducts a confirmatory test (Western Blot) to confirm
positivity. Results come back positive again. Provider then diagnoses patient as HIV (ICD9: 042).
The provider orders lab work which includes a Viral Load and CD4 test. If VL > 200, an alert
triggers “unsuppressed viral load”, and if CD4 < 200, another alert triggers “Below normal
5
range”. Provider uses the CDSS systemto prescribe antiretroviral therapy and to check for any
allergies/drug to drug interaction.
Scenario name: Viral Load Suppression, CD4 monitor, and Drug to Drug interaction
Decision made by the scenario: To find out if an HIV positive patient has a detectable viral load
(VL > 200), a CD4 count < 200, and an adverse drug reaction to antiretroviral therapy. This will
be used to monitor health status of the patient.
Actors: Medical Personnel, Clinician
Description: The medical personnel will draw blood to check if viral load is suppressed, if CD4
count is within normal range, and if there are any adverse drug reactions
Use case name: VL suppression and CD4 normal range
Overview: The purpose of this use case is to routine test see if a patient is HIV positive. HIV test
comes back positive and nurse schedules same day appointment is scheduled for patient to see
provider. Provider diagnoses patient does confirmatory test and diagnoses patient with HIV.
(ICD-9: 042). Orders viral load and CD4 count to check normalcy and check for drug
interactions.
Start point: Nurse, Phlebotomist, or Community Health Educator tests patient for HIV. Results
come back positive. Western blot is performed for confirmatory test. Results come back
positive again.
End Point: Provider diagnoses patient and orders a viral load and CD4 test. Patient results show
that VL level is higher than normal and CD4 is below the normal range. Provider prescribes
antiretroviral therapy to patient. Check for any allergies. Allergy alert triggers and provider
prescribes appropriate medications.
Information Exchange: The information about the patient is entered into the system and the
provider will monitor the patient’s health outcomes over a period of time.
ENTITY RELATIONSHIP DIAGRAM:
6
7
Implementation:
Scenario 1 Implementation:
HIV Tester and Tracker
Step 1: A provider, nurse or community health educator conducts risk assessment of patient.
Enters patient demographics, and asks a series of 7 standardized questions.
Step 2: If patient answers “yes” to 5 questions or more, an alert will appear indicating the
patient is “high risk”
Step 3: The medical personnel (who could be a nurse, community health worker, or a clinician)
will then recommend an HIV test to the patient in attempt to promote risk reduction efforts
Step 4: HIV ELISA test is performed and noted. Based on the negative result, an alert will appear
indicating the patient is fine but will recommend PrEP for prevention strategy against the
exposure to HIV. Patient accepts recommendation and physician prescribes PreP to be taking
daily. Physician also educates patient about the impact of high risk sexual behaviors.
Scenario 2 Implementation:
Step 1: Patient walks in for HIV test with complaints of having flu-like symptoms. The Medical
personnel perform an HIV test (ELISA). The result comes back positive.
Step 2: The patient is sent to a provider who will conduct a confirmatory test (Western blot) to
make sure this is not a false-positive. The clinician orders the confirmatory test to evaluate true
positivity.
Step 3: The clinician diagnoses the patient with an ICD-9 “042” indicating “HIV”. The clinician
then explains the results to the patient and orders some additional labs to be performed such
as Viral Load, and CD4 tests.
Step 4: The clinician reviews the labs and based on if the values for the viral load are > 200 or
CD4 < 200, an alert will appear indicating an “unsuppressed’ VL and CD4 count “lower than
normal range”.
Step 5: The clinician clicks the “e-prescription” tab in the systemto prescribe antiretroviral
therapy.
Step 6: The clinician uses the CDSS to check for any drug interactions. If patient has any
allergies, an alert will appear indicating that an alternative medication should be prescribed.
Step 7: The clinician puts in prescription order for Stribild and Complera.
8
Fully systemspecification:
ENTITY RELATIONSHIP IN MS ACCESS
9
Based on the patient’s answers to the risk assessment questions, an automatic high risk alert is
triggered.
10
Although the patient tested negative for HIV, there will be another alert indicating a prevention
recommendation for PreP based on the patient’s risk factors.
11
Alternatively, let’s see what happens if a patient tests positive to HIV. All steps listed earlier
should reflect in the following screenshots:
12
13
14
15
16
CDSS
Conclusion:
CDSS and alerts are very important tools in clinical decision making. Whether it’s checking to
see patients risk stratification, or alerts when labs are abnormal, or when there is an adverse
drug reaction, CDSS proves to be a useful tool in guiding clinicians. This systemimproves the
quality of care, overall patient satisfaction, and ultimately reduces cost for both patient and
provider- achieving the IOM (Institute of Medicine) Triple Aim model. HIV is not a death
sentence and as long as people practice safe sex and monitor their sexual behavior regularly,
their risk significantly diminishes.
References:
1. Center for Disease Control and Prevention. (Jan, 2015). HIV/AIDS. Retrieved from:
http://www.cdc.gov/hiv/basics/whatishiv.html
2. AIDSMap. (July, 2012). HIV/AIDS- sharing knowledge, changing lives. Retrieved from:
http://www.aidsmap.com/Viral-load/page/1327496/
3. AIDS.gov. (March, 2015). HIV/AIDS Basics. Retrieved from: https://www.aids.gov/hiv-
aids-basics/just-diagnosed-with-hiv-aids/understand-your-test-results/viral-load/
17
4. AIDS.gov. (Sep, 2014). HIV/AIDS Basics. Retrieved from: https://www.aids.gov/hiv-aids-
basics/just-diagnosed-with-hiv-aids/understand-your-test-results/cd4-count/
5. Health Resources and Services Administration. (2015). About Ryan White HIV/AIDS
Program. Retrieved from: http://hab.hrsa.gov/abouthab/aboutprogram.html
Entities considered for this prototype:
Field Name Type Data Format Source of Data Intended Use of Data Description
patient_id Number Number
Entered by
front desk
staff
Used to identify patient
records within the
system and paper
records outsidethe
system
Clinic’s internal
patient identifier
(medical record
number); must be
unique to patient
within your
organization
dob
Date/Time Date Entered by
front desk
staff
Used to calculateage
of patient
Patient’s date of
birth
YYYY-MM-DD
gender Text Text
Entered by
front desk
staff
Used to identify patient
by race
Patient’s gender
First_name Text
Entered by
front desk
staff
Used to identify patient
by firstname
Patient's last
(family) name
Last_Name Text Text
Entered by
front desk
staff
Used to identify patient
by lastname
Patient’s, first
(given) name
pcp_id Text Text
Assigned by
front desk
staff
Used to assign patient
to a primary care
physician
ID of the patient’s
primary care
physician (as
indicated in the
"Providers"file)
ethnicity Text Text
Entered by
front desk
staff
Used to identify patient
by ethnicity
Patient’s ethnicity
race Text Text
Entered by
front desk
staff
Used to identify patient
by race
Primary racewith
which patient
identifies.
EncounterID Number 999.9
Generated
usingAccess
database
Used to identify each
unique patient
appointment
Each patient
appointment has
a unique identifier
for querying
purposes
18
ApptDate Date/Time mm/dd/yyyy
Entered by
front desk
staff
Used to identify the
date of appointment
Patient
appointment date
StartTime Date/Time Date/Time
Entered by
front desk
staff
Used to identify the
starttime for each
appointment
Start time for
each appointment
endTime Date/Time Date/Time
Entered by
front desk
staff
Used to identify the
end time for each
appointment
End time for each
appointment
provider_id Text Text
Entered by
front desk
staff
Used to identify the
Primary CarePhysician
for each patient
Provider ID
(correspondingto
the provider
record in the
“Providers”file) of
the provider that
performed the
procedure.
DiagCode Text Text
Entered by
clinician
Used to identify the
ICD-9 diagnosiscodes
associated with each
appointment
The diagnosis
code
nomenclature
used to code the
firstdiagnosis
associated with
the current
procedure.
ICD_Code Text Text
Entered by
clinician
Used to identify
diagnosiscodes and
problem lists
The diagnosis
code
nomenclature
used to code the
diagnosis.
ICD_Description Text Text
Entered by
clinician
Used to identify
diagnosisdescription
The descriptive
label for diagnosis
code.
Lab_date
Date Date Entered by
medical
personnel
Used to identify the
date the lab test was
performed
The date on which
the current
measurement was
taken.
YYYY-MM-
DD
YYYY-MM-DD
19
Lab_ID Integer Integer
Entered by
medical
personnel
Used to identify unique
lab tests in the HER
An identifier used
to uniquely
identify the
observation
within the client’s
EHR/Reporting
System.
LabName Text Text
Entered by
medical
personnel
Used to identify the
name of the lab test
that was administered
The descriptive
label for the type
of observation
being reported
LabValue Text String
Entered by
medical
personnel
Used to identify the lab
result
The raw valueof
the measurement
associated with
the current
observation.
Note: Blood
Pressurecan be
sent as one
“systolic/diastolic”
stringvalue
order_date
Date Date
Entered by
clinician
Used to identify date of
prescription
Date medication
was orderedYYYY-MM-
DD
YYYY-MM-DD
MedName Text Text
Prescribed by
Physician
To improve or maintain
the condition of the
patient
Medication
description
associated with
the current
drug_code in the
current record
provider_id Number Auto Number
Automatically
generated by
Access
database
Used to identify each
unique provider within
an organization
Clinic’s internal
provider
identifier. This
field should
accurately match
the current
provider to the
encounters for
which they were
the identified
provider in the
“encounters” file.
provider_name Text Text
20
Entered by IT
administrator
or medical
personnel into
the EHR
Used to identify
provider by name and
credentials i.eMD, PA,
RN etc.
Provider’s name
as you wish for it
to appear in EHR
AgentSubstance Text Text
Entered by
clinician
Used to identify any
allergies to medications
Allergy name
Reaction Text Text
Entered by
clinician
Used to identify the
reaction caused by
allergy
Reaction to
allergic substance
i.e itching
RiskFactors Text Text
Entered by
medical
personnel
Used to identify risk
factors for HIV
Listof
standardized
questions for HIV
Risk Assessment
Result Text Text
Entered by
medical
personnel
Used to identify answer
to risk assessmenti.e
"Yes" or "No"
Yes or No answers
only

More Related Content

What's hot

A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013Hivlife Info
 
Hiv aids lecture
Hiv aids lectureHiv aids lecture
Hiv aids lectureTeamPulaw
 
Cdc hiv-genepislideseries-2013
Cdc hiv-genepislideseries-2013Cdc hiv-genepislideseries-2013
Cdc hiv-genepislideseries-2013Richin Koshy
 
Hiv Aids Bloodborne Pathogens
Hiv Aids Bloodborne PathogensHiv Aids Bloodborne Pathogens
Hiv Aids Bloodborne Pathogensguest1a1011
 
HIV - AIDS. Associated Infections and Invasions
HIV - AIDS. Associated Infections and InvasionsHIV - AIDS. Associated Infections and Invasions
HIV - AIDS. Associated Infections and InvasionsEneutron
 
Aids Powerpoint
Aids PowerpointAids Powerpoint
Aids Powerpointjoeyprince
 
Adult HIV: Skills workshop screening tests for HIV
Adult HIV: Skills workshop screening tests for HIVAdult HIV: Skills workshop screening tests for HIV
Adult HIV: Skills workshop screening tests for HIVPiLNAfrica
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDSadroits
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"HopkinsCFAR
 
Hiv Case Study Presentation
Hiv Case Study PresentationHiv Case Study Presentation
Hiv Case Study Presentationjeska62
 
Hiv Aids Best
Hiv Aids BestHiv Aids Best
Hiv Aids Bestadroits
 
August 2013 PLUS HIV Treatment
August 2013 PLUS HIV TreatmentAugust 2013 PLUS HIV Treatment
August 2013 PLUS HIV TreatmentPositive_Force
 
Hiv epi, diagnosis and treatment
Hiv epi, diagnosis and treatmentHiv epi, diagnosis and treatment
Hiv epi, diagnosis and treatmentAshok Chandana
 

What's hot (19)

A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013
 
Hiv aids lecture
Hiv aids lectureHiv aids lecture
Hiv aids lecture
 
Cdc hiv-genepislideseries-2013
Cdc hiv-genepislideseries-2013Cdc hiv-genepislideseries-2013
Cdc hiv-genepislideseries-2013
 
Hiv Aids Bloodborne Pathogens
Hiv Aids Bloodborne PathogensHiv Aids Bloodborne Pathogens
Hiv Aids Bloodborne Pathogens
 
HIV - AIDS. Associated Infections and Invasions
HIV - AIDS. Associated Infections and InvasionsHIV - AIDS. Associated Infections and Invasions
HIV - AIDS. Associated Infections and Invasions
 
Aids Powerpoint
Aids PowerpointAids Powerpoint
Aids Powerpoint
 
Adult HIV: Skills workshop screening tests for HIV
Adult HIV: Skills workshop screening tests for HIVAdult HIV: Skills workshop screening tests for HIV
Adult HIV: Skills workshop screening tests for HIV
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
 
Hivaids Fa07
Hivaids Fa07Hivaids Fa07
Hivaids Fa07
 
Hiv Case Study Presentation
Hiv Case Study PresentationHiv Case Study Presentation
Hiv Case Study Presentation
 
HIV-AIDS
HIV-AIDSHIV-AIDS
HIV-AIDS
 
Hiv Aids Best
Hiv Aids BestHiv Aids Best
Hiv Aids Best
 
AIDS
AIDSAIDS
AIDS
 
August 2013 PLUS HIV Treatment
August 2013 PLUS HIV TreatmentAugust 2013 PLUS HIV Treatment
August 2013 PLUS HIV Treatment
 
Know Aids No Aids
Know Aids No AidsKnow Aids No Aids
Know Aids No Aids
 
AIDS
AIDSAIDS
AIDS
 
Hiv aids
Hiv aidsHiv aids
Hiv aids
 
Hiv epi, diagnosis and treatment
Hiv epi, diagnosis and treatmentHiv epi, diagnosis and treatment
Hiv epi, diagnosis and treatment
 

Similar to HAP 752 Semester Long Project Write-Up Koyin Aladesuru Linkedin

Management of patient with AIDS
Management of patient with AIDSManagement of patient with AIDS
Management of patient with AIDSMathew Varghese V
 
HIV/AIDS REPORT MT LAWS
HIV/AIDS REPORT MT LAWSHIV/AIDS REPORT MT LAWS
HIV/AIDS REPORT MT LAWSqncyamresss
 
A basic understanding of HIV surveillance
A basic understanding of HIV surveillanceA basic understanding of HIV surveillance
A basic understanding of HIV surveillanceDr.RAJEEV KASHYAP
 
Hiv eye update 2013
Hiv eye update 2013Hiv eye update 2013
Hiv eye update 2013etedaldi
 
Basics of HIV AIDS.pptx
Basics of HIV AIDS.pptxBasics of HIV AIDS.pptx
Basics of HIV AIDS.pptxchcjayanagara
 
Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024Motahar Alam
 
1Final Course Project OutlineFinal Course Project Outlin
1Final Course Project OutlineFinal Course Project Outlin1Final Course Project OutlineFinal Course Project Outlin
1Final Course Project OutlineFinal Course Project OutlinAnastaciaShadelb
 
projectblack-210316180313(1).pdf
projectblack-210316180313(1).pdfprojectblack-210316180313(1).pdf
projectblack-210316180313(1).pdfsaralamaharajan2402
 
Hiv and its treatment
Hiv and its treatmentHiv and its treatment
Hiv and its treatmentMicrobiology
 
Hiv and its treatment
Hiv and its treatmentHiv and its treatment
Hiv and its treatmentMicrobiology
 
Hiv and its treatment
Hiv and its treatmentHiv and its treatment
Hiv and its treatmentMicrobiology
 
AIDS/HIV Quick Guide
AIDS/HIV Quick GuideAIDS/HIV Quick Guide
AIDS/HIV Quick Guidegaby350
 

Similar to HAP 752 Semester Long Project Write-Up Koyin Aladesuru Linkedin (20)

Management of patient with AIDS
Management of patient with AIDSManagement of patient with AIDS
Management of patient with AIDS
 
Aids
AidsAids
Aids
 
AIDS
AIDSAIDS
AIDS
 
HIV/AIDS REPORT MT LAWS
HIV/AIDS REPORT MT LAWSHIV/AIDS REPORT MT LAWS
HIV/AIDS REPORT MT LAWS
 
A basic understanding of HIV surveillance
A basic understanding of HIV surveillanceA basic understanding of HIV surveillance
A basic understanding of HIV surveillance
 
AIDs.pptx
AIDs.pptxAIDs.pptx
AIDs.pptx
 
AIDS and HEPATITIS
AIDS and HEPATITIS  AIDS and HEPATITIS
AIDS and HEPATITIS
 
HIV and AIDS
HIV and AIDSHIV and AIDS
HIV and AIDS
 
Hiv eye update 2013
Hiv eye update 2013Hiv eye update 2013
Hiv eye update 2013
 
Human immunodeficiency virus
Human immunodeficiency virusHuman immunodeficiency virus
Human immunodeficiency virus
 
Basics of HIV AIDS.pptx
Basics of HIV AIDS.pptxBasics of HIV AIDS.pptx
Basics of HIV AIDS.pptx
 
Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024
 
1Final Course Project OutlineFinal Course Project Outlin
1Final Course Project OutlineFinal Course Project Outlin1Final Course Project OutlineFinal Course Project Outlin
1Final Course Project OutlineFinal Course Project Outlin
 
projectblack-210316180313(1).pdf
projectblack-210316180313(1).pdfprojectblack-210316180313(1).pdf
projectblack-210316180313(1).pdf
 
Hiv and its treatment
Hiv and its treatmentHiv and its treatment
Hiv and its treatment
 
Hiv and its treatment
Hiv and its treatmentHiv and its treatment
Hiv and its treatment
 
Hiv and its treatment
Hiv and its treatmentHiv and its treatment
Hiv and its treatment
 
Hiv dr.tanushka
Hiv dr.tanushkaHiv dr.tanushka
Hiv dr.tanushka
 
HIV-AIDS.ppt
HIV-AIDS.pptHIV-AIDS.ppt
HIV-AIDS.ppt
 
AIDS/HIV Quick Guide
AIDS/HIV Quick GuideAIDS/HIV Quick Guide
AIDS/HIV Quick Guide
 

HAP 752 Semester Long Project Write-Up Koyin Aladesuru Linkedin

  • 1. 1 Koyin Aladesuru 4/16/2015 HAP 752- AdvancedHealthInformationSystems Semester Long Project HIV (Human Immunodeficiency Disease) Introduction: There was once upon a time when the word HIV seemed like a taboo, and the mere mention of the word could have one glance at you with a death sentence stare. HIV, also known as Human Immunodeficiency Virus, spreads through body fluids that affect vital cells in the immune system. Without treatment, HIV often leads to AIDS (Acquired Immunodeficiency Syndrome), an advance stage of HIV that destroys several cells in the body and makes one prone to opportunistic infections and diseases. HIV can be transmitted through a list of possible risk factors such as number of sexual partners, condom usage, injection drug users, sexual orientation, history of STD’s, or even geographical location. According to recent statistics provided by the Center for Disease Control and Prevention (CDC), there are about 50,000 new HIV infections per year and approximately 1.2 million people in the United States were living with HIV at the end of 2011. Fortunately however, with the advancement of antiretroviral therapy (ART) and proper medical care, HIV is no longer a death sentence. Antiretroviral therapy, which was introduced in the mid-1990’s, has proven to be a life saver in the fight against HIV. The goal of this project is to build a system that allows healthcare providers to conduct a thorough risk assessment for HIV, recommend effective prevention methods, track lab values for patients, show trend of values over time, detect abnormal results, and identify adverse drug reactions. Background: HIV can be broken up into three stages: 1. Acute infection: This stage is typically within 2 to 4 weeks after infection of HIV, and the word “acute” implies that this is when one is at the highest risk of spreading the disease. This is also the period when one may display symptoms such as fever, fatigue, cough, shortness of breath, sore throat, rash, and enlarge lymph nodes. 2. Clinical latency (inactivity or dormancy): This stage is often referred to as HIV asymptomatic, where one may display little to no symptoms. Typically, people who are adherent to antiretroviral therapy during this stage can maintain clinical latency for a long period of time (usually several decades). Towards the latter end of this stage however, the viral load (amount of virus in the blood) usually increases, while the CD4 T-
  • 2. 2 cells (white blood cells in the body) begins to drop. The immune systemgets weaker at this point. 3. AIDS (Acquired Immunodeficiency Syndrome): As the immune system progressively gets weaker, one becomes severely exposed to opportunistic infections and cancer. When the CD4 count falls below 200 cells/mm^3, one may be diagnosed as AIDS. Although, it is important to note that one can also be diagnosed as AIDS once one develops one or more opportunistic infections, regardless of CD4 count. A normal range for a CD4 count falls between 500 and 1,200 cells/mm^3. CDC points out that without treatment, people diagnosed with AIDS survive an average of 3 years life expectancy. HIV Testing Know your HIV status- is the recurring mantra that has been floating around our society for several decades. Risk assessment and routine testing for HIV is very important, particularly amongst younger adults who may be at a higher risk of exposure. In the public health community, it is not uncommon to hear that a sexually active person has never been tested for HIV. ELISA, also known as Enzyme-Linked Immuno Assay, is a widely used laboratory test to detect HIV antibodies in the blood. It can detect HIV as early as 3 weeks after exposure and if a patient tests positive, they further undergo a confirmatory test, known as a Western Blot, to confirm positivity. In order to screen out false-positive results, which happen in rare cases, it is important to supplement an ELISA test with a Western Blot test. Subsequently, a clinician then orders a Viral Load and CD4 test which we’ll discuss in the next few sections. Viral Load This is a term used to describe the amount of virus in the blood. In clinician language, viral Load can be described as the number of copies of HIV RNA in a milliliter of blood. In simple terms, the more HIV spreads in your blood, the higher your viral load. Viral load is a useful metric to measure the health status of an HIV patient and the impact of antiretroviral therapy on their health. It is recommended to look at a trend of viral load over time (we will discuss this later on in the project). Compared to hypertension, diabetes, or some other chronic diseases, HIV does not necessarily have a specific range/cutoff for a “normal” viral load. According to the Health Resources and Services Administration (HRSA), viral count can be measured using the following data criteria: Suppressed (Undetectable level): < 200 copies/mL Unsuppressed (Detectable level): > 200 copies /mL CD4 Count: CD4 T-cells, also known as “CD4 Count”, are white blood cells that protect the immune system. A CD4 test measures the amount of T-cells in the body. As the CD4 count decreases, the risk of developing opportunistic infections increases. As I mentioned earlier, a CD4 count less than 200 cells/mm^3 is considered below normal range and it indicates that HIV is advancing to AIDS.
  • 3. 3 According to the Health Resources and Services Administration (HRSA), CD4 count can be measured using the following data criteria: Normal range: 500 – 1,200 cells/mm^3 Below normal range: < 200 cells/mm^3 PrEP: Pre-exposure prophylaxis, also known as PrEP, is an effective prevention option for people who are at high risk of getting HIV. CDC recommends PrEP for people who are HIV-negative but are at substantial risk for the disease. PrEP is taking in the form of a pill called Truvada and is recommended to be taking daily to prevent HIV. According to a PreP study conducted, the risk of getting HIV infection was about 92% lower for patients who took Truvada consistently. Part of this project will explore a scenario where a provider conducts a risk assessment for a patient recently exposed to HIV, performs an HIV test (which comes back negative), and recommends PreP as an effective risk reduction method. ALERTS and Clinical Decision Support Systems (CDSS): In order for health providers to make accurate and effective clinical decisions, a data system should be able to trigger a series of alerts or warnings to guide them during treatment. Data mining helps physicians, nurses, and other health professionals predict the likelihood of an event occurring. This could range from risk stratification of a particular disease, to disease management and adverse drug interactions. Keep in mind that it is important not to overwhelm providers with alerts, particularly for less urgent clinical decisions. A clinician will be able to achieve the following with this system: 1. Identify patients who are at risk of getting HIV 2. Prescribe PrEP as an effective prevention method 3. Monitor viral load count for HIV positive clients 4. Monitor CD4 count and prescribe PCP Prophylaxis if CD4 count drops below 200 5. Prescribe antiretroviral medications and check for any drug interactions/allergies 6. View a graphical trend of viral load performance RequirementsSpecification: Scenario 1 A patient comes in for a routine HIV test. A nurse/community health educator uses a risk assessment screening tool to measure the patients risk for HIV. Out of 9 standardized questions, if the patient answers “Yes” to 5 or more, an alert will be triggered as “high risk”.
  • 4. 4 The medical personnel will then perform an HIV (ELISA) test and if the test comes out negative, a clinician will suggest/prescribe PreP as an effective risk reduction method. Scenario name: Risk assessment and PrEP prescription Decision made by the scenario: CDSS will help determine if patient is at substantial risk of getting HIV and alert the provider to offer PrEP as a preventive option. Actors: Medical Personnel, Patient Description: The medical personnel can use the clinical decision support system to conduct a risk assessment and prescribe PrEP to HIV-negative patients who are high risk of exposure to HIV. Use case name: CDSS utilization Overview: HIV has a high correlation with sexual behaviors. The purpose of this use case is to identify a patient who is at increased risk of exposure to the disease. If they answer yes to 5 or more risk assessment questions, a provider will offer the option of PrEP in order to mitigate their risk. Primary actor: Medical staff (Phlebotomist, Nurse, Community Health educator) Secondary actor: Clinicians Start point: The medical staff performs a risk assessment of patient sexual behaviors. If patient scores more than 5 out of 9 standardized questions, a “high risk alert” will pop up. Medical personnel will the recommend an HIV test End point: The provider reviews lab results and utilizes the clinical decision support systemto offer PrEP to patient Information Exchange: The information about potential risk factors is entered into a patient’s sexual risk assessment screening tool. The provider will use the CDSS tool to identify if the patient is high risk, perform HIV test, and recommend risk prevention treatment as needed i.e. PrEP. Scenario 2: A patient walks in for a routine HIV test. The medical personnel administer an ELISA test and the result comes back positive. Provider conducts a confirmatory test (Western Blot) to confirm positivity. Results come back positive again. Provider then diagnoses patient as HIV (ICD9: 042). The provider orders lab work which includes a Viral Load and CD4 test. If VL > 200, an alert triggers “unsuppressed viral load”, and if CD4 < 200, another alert triggers “Below normal
  • 5. 5 range”. Provider uses the CDSS systemto prescribe antiretroviral therapy and to check for any allergies/drug to drug interaction. Scenario name: Viral Load Suppression, CD4 monitor, and Drug to Drug interaction Decision made by the scenario: To find out if an HIV positive patient has a detectable viral load (VL > 200), a CD4 count < 200, and an adverse drug reaction to antiretroviral therapy. This will be used to monitor health status of the patient. Actors: Medical Personnel, Clinician Description: The medical personnel will draw blood to check if viral load is suppressed, if CD4 count is within normal range, and if there are any adverse drug reactions Use case name: VL suppression and CD4 normal range Overview: The purpose of this use case is to routine test see if a patient is HIV positive. HIV test comes back positive and nurse schedules same day appointment is scheduled for patient to see provider. Provider diagnoses patient does confirmatory test and diagnoses patient with HIV. (ICD-9: 042). Orders viral load and CD4 count to check normalcy and check for drug interactions. Start point: Nurse, Phlebotomist, or Community Health Educator tests patient for HIV. Results come back positive. Western blot is performed for confirmatory test. Results come back positive again. End Point: Provider diagnoses patient and orders a viral load and CD4 test. Patient results show that VL level is higher than normal and CD4 is below the normal range. Provider prescribes antiretroviral therapy to patient. Check for any allergies. Allergy alert triggers and provider prescribes appropriate medications. Information Exchange: The information about the patient is entered into the system and the provider will monitor the patient’s health outcomes over a period of time. ENTITY RELATIONSHIP DIAGRAM:
  • 6. 6
  • 7. 7 Implementation: Scenario 1 Implementation: HIV Tester and Tracker Step 1: A provider, nurse or community health educator conducts risk assessment of patient. Enters patient demographics, and asks a series of 7 standardized questions. Step 2: If patient answers “yes” to 5 questions or more, an alert will appear indicating the patient is “high risk” Step 3: The medical personnel (who could be a nurse, community health worker, or a clinician) will then recommend an HIV test to the patient in attempt to promote risk reduction efforts Step 4: HIV ELISA test is performed and noted. Based on the negative result, an alert will appear indicating the patient is fine but will recommend PrEP for prevention strategy against the exposure to HIV. Patient accepts recommendation and physician prescribes PreP to be taking daily. Physician also educates patient about the impact of high risk sexual behaviors. Scenario 2 Implementation: Step 1: Patient walks in for HIV test with complaints of having flu-like symptoms. The Medical personnel perform an HIV test (ELISA). The result comes back positive. Step 2: The patient is sent to a provider who will conduct a confirmatory test (Western blot) to make sure this is not a false-positive. The clinician orders the confirmatory test to evaluate true positivity. Step 3: The clinician diagnoses the patient with an ICD-9 “042” indicating “HIV”. The clinician then explains the results to the patient and orders some additional labs to be performed such as Viral Load, and CD4 tests. Step 4: The clinician reviews the labs and based on if the values for the viral load are > 200 or CD4 < 200, an alert will appear indicating an “unsuppressed’ VL and CD4 count “lower than normal range”. Step 5: The clinician clicks the “e-prescription” tab in the systemto prescribe antiretroviral therapy. Step 6: The clinician uses the CDSS to check for any drug interactions. If patient has any allergies, an alert will appear indicating that an alternative medication should be prescribed. Step 7: The clinician puts in prescription order for Stribild and Complera.
  • 9. 9 Based on the patient’s answers to the risk assessment questions, an automatic high risk alert is triggered.
  • 10. 10 Although the patient tested negative for HIV, there will be another alert indicating a prevention recommendation for PreP based on the patient’s risk factors.
  • 11. 11 Alternatively, let’s see what happens if a patient tests positive to HIV. All steps listed earlier should reflect in the following screenshots:
  • 12. 12
  • 13. 13
  • 14. 14
  • 15. 15
  • 16. 16 CDSS Conclusion: CDSS and alerts are very important tools in clinical decision making. Whether it’s checking to see patients risk stratification, or alerts when labs are abnormal, or when there is an adverse drug reaction, CDSS proves to be a useful tool in guiding clinicians. This systemimproves the quality of care, overall patient satisfaction, and ultimately reduces cost for both patient and provider- achieving the IOM (Institute of Medicine) Triple Aim model. HIV is not a death sentence and as long as people practice safe sex and monitor their sexual behavior regularly, their risk significantly diminishes. References: 1. Center for Disease Control and Prevention. (Jan, 2015). HIV/AIDS. Retrieved from: http://www.cdc.gov/hiv/basics/whatishiv.html 2. AIDSMap. (July, 2012). HIV/AIDS- sharing knowledge, changing lives. Retrieved from: http://www.aidsmap.com/Viral-load/page/1327496/ 3. AIDS.gov. (March, 2015). HIV/AIDS Basics. Retrieved from: https://www.aids.gov/hiv- aids-basics/just-diagnosed-with-hiv-aids/understand-your-test-results/viral-load/
  • 17. 17 4. AIDS.gov. (Sep, 2014). HIV/AIDS Basics. Retrieved from: https://www.aids.gov/hiv-aids- basics/just-diagnosed-with-hiv-aids/understand-your-test-results/cd4-count/ 5. Health Resources and Services Administration. (2015). About Ryan White HIV/AIDS Program. Retrieved from: http://hab.hrsa.gov/abouthab/aboutprogram.html Entities considered for this prototype: Field Name Type Data Format Source of Data Intended Use of Data Description patient_id Number Number Entered by front desk staff Used to identify patient records within the system and paper records outsidethe system Clinic’s internal patient identifier (medical record number); must be unique to patient within your organization dob Date/Time Date Entered by front desk staff Used to calculateage of patient Patient’s date of birth YYYY-MM-DD gender Text Text Entered by front desk staff Used to identify patient by race Patient’s gender First_name Text Entered by front desk staff Used to identify patient by firstname Patient's last (family) name Last_Name Text Text Entered by front desk staff Used to identify patient by lastname Patient’s, first (given) name pcp_id Text Text Assigned by front desk staff Used to assign patient to a primary care physician ID of the patient’s primary care physician (as indicated in the "Providers"file) ethnicity Text Text Entered by front desk staff Used to identify patient by ethnicity Patient’s ethnicity race Text Text Entered by front desk staff Used to identify patient by race Primary racewith which patient identifies. EncounterID Number 999.9 Generated usingAccess database Used to identify each unique patient appointment Each patient appointment has a unique identifier for querying purposes
  • 18. 18 ApptDate Date/Time mm/dd/yyyy Entered by front desk staff Used to identify the date of appointment Patient appointment date StartTime Date/Time Date/Time Entered by front desk staff Used to identify the starttime for each appointment Start time for each appointment endTime Date/Time Date/Time Entered by front desk staff Used to identify the end time for each appointment End time for each appointment provider_id Text Text Entered by front desk staff Used to identify the Primary CarePhysician for each patient Provider ID (correspondingto the provider record in the “Providers”file) of the provider that performed the procedure. DiagCode Text Text Entered by clinician Used to identify the ICD-9 diagnosiscodes associated with each appointment The diagnosis code nomenclature used to code the firstdiagnosis associated with the current procedure. ICD_Code Text Text Entered by clinician Used to identify diagnosiscodes and problem lists The diagnosis code nomenclature used to code the diagnosis. ICD_Description Text Text Entered by clinician Used to identify diagnosisdescription The descriptive label for diagnosis code. Lab_date Date Date Entered by medical personnel Used to identify the date the lab test was performed The date on which the current measurement was taken. YYYY-MM- DD YYYY-MM-DD
  • 19. 19 Lab_ID Integer Integer Entered by medical personnel Used to identify unique lab tests in the HER An identifier used to uniquely identify the observation within the client’s EHR/Reporting System. LabName Text Text Entered by medical personnel Used to identify the name of the lab test that was administered The descriptive label for the type of observation being reported LabValue Text String Entered by medical personnel Used to identify the lab result The raw valueof the measurement associated with the current observation. Note: Blood Pressurecan be sent as one “systolic/diastolic” stringvalue order_date Date Date Entered by clinician Used to identify date of prescription Date medication was orderedYYYY-MM- DD YYYY-MM-DD MedName Text Text Prescribed by Physician To improve or maintain the condition of the patient Medication description associated with the current drug_code in the current record provider_id Number Auto Number Automatically generated by Access database Used to identify each unique provider within an organization Clinic’s internal provider identifier. This field should accurately match the current provider to the encounters for which they were the identified provider in the “encounters” file. provider_name Text Text
  • 20. 20 Entered by IT administrator or medical personnel into the EHR Used to identify provider by name and credentials i.eMD, PA, RN etc. Provider’s name as you wish for it to appear in EHR AgentSubstance Text Text Entered by clinician Used to identify any allergies to medications Allergy name Reaction Text Text Entered by clinician Used to identify the reaction caused by allergy Reaction to allergic substance i.e itching RiskFactors Text Text Entered by medical personnel Used to identify risk factors for HIV Listof standardized questions for HIV Risk Assessment Result Text Text Entered by medical personnel Used to identify answer to risk assessmenti.e "Yes" or "No" Yes or No answers only